PULSE INTRAVENOUS CLOMIPRAMINE IN DEPRESSED ADOLESCENTS
PULSE INTRAVENOUS CLOMIPRAMINE IN DEPRESSED ADOLESCENTS
批准号:
5222324
负责人:
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
研究了青少年抑郁症(MDD)的低血清素能假说
英文摘要
The hyposerotonergic hypothesis of adolescent depression (MDD) is examined
a
3 pathways: 1) low dose (12.5 mg) IV clomipramine (CMI) as a serotonergic
robe
in adolescent MDD compared to matched controls as a potential marker, and
assessment pre and post treatment with an SRI as a potential trait marker o
MDD
in this population; 3) use of high dose (200mg) pulse IV CMI (an SRI when g
en
IV) to determine acute efficacy in adolescent MDD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金